Published Paper Details:

Shirishavaleha, an Ayurvedic formulation primarily composed of Shirisha (Albizia lebbeck), is traditionally known for its anti-inflammatory, antimicrobial, and detoxifying properties. This review examines the potential therapeutic application of Shirishavaleha in the management of allergic conjunctivitis, a common eye condition characterized by inflammation of the conjunctiva due to allergic reactions. Shirisha's anti-inflammatory, immunomodulatory, and detoxifying properties are beneficial in alleviating the congestion, irritation, and excessive discharge associated with Abhishyanda. The formulation works by balancing Kapha, reducing ocular inflammation, and promoting the clearance of toxins, which may help in managing allergic reactions and relieving symptoms of conjunctival inflammation. Additionally, the antimicrobial and antioxidant properties of Shirishavaleha may aid in preventing secondary infections and protecting the eyes from oxidative damage. Standardization of the compound formulation is the need of the present era to set standards for maintaining the quality of the products. Here an attempt has been made to study Shirishavaleha pharmacognostically, analytically and to develop fingerprints by High-Performance Thin Layer chromatography study (HPTLC).